Fetal Fibroblasts and Keratinocytes with Immunosuppressive Properties for Allogeneic Cell-Based Wound Therapy

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Zuliani, Thomas ^a   Saiagh, Soraya ^a   Knol, Anne Chantal ^a   Esbelin, Julie ^b   Dréno, Brigitte ^a  

^a HÔTEL DIEU   (France)

^b HME Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 8; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; SCATTER FACTOR;

ALLOGENIC CELL BASED WOUND THERAPY; ARTICLE; CELL CULTURE; CELL INTERACTION; CELL PROLIFERATION; CELL THERAPY; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; FETUS; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; KERATINOCYTE; LANGERHANS CELL; MELANOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; SKIN INJURY; WOUND HEALING;

EID: 84880830829     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070408     Document Type: Article

References (51)

1. Clark RA, Ghosh K, Tonnesen MG, (2007) Tissue engineering for cutaneous wounds. J Invest Dermatol 127: 1018-1029.
2. Shakespeare PG, (2005) The role of skin substitutes in the treatment of burn injuries. Clin Dermatol 23: 413-418.
3. MacNeil S, (2007) Progress and opportunities for tissue-engineered skin. Nature 445: 874-880.
4. Mansbridge JN, (2009) Tissue-engineered skin substitutes in regenerative medicine. Curr Opin Biotechnol 20: 563-567.
5. Priya SG, Jungvid H, Kumar A, (2008) Skin tissue engineering for tissue repair and regeneration. Tissue Eng Part B Rev 14: 105-118.
6. Gallico GG, 3rd, O'Connor NE, Compton CC, Kehinde O, Green H (1984) Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311: 448-451.
7. He C, Heeger PS, (2004) CD8 T cells can reject major histocompatibility complex class I-deficient skin allografts. Am J Transplant 4: 698-704.
8. Funeshima-Fuji N, Fujino M, Kimura H, Takahara S, Nakayama T, et al. (2008) Survival of skin allografts is prolonged in mice with a dominant-negative H-Ras. Transpl Immunol 18: 302-306.
9. Still J, Glat P, Silverstein P, Griswold J, Mozingo D, (2003) The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns 29: 837-841.
10. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, et al. (1998) Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 134: 293-300.
11. Yang GP, Lim IJ, Phan TT, Lorenz HP, Longaker MT, (2003) From scarless fetal wounds to keloids: molecular studies in wound healing. Wound Repair Regen 11: 411-418.
12. Larson BJ, Longaker MT, Lorenz HP, (2010) Scarless fetal wound healing: a basic science review. Plast Reconstr Surg 126: 1172-1180.
13. Gurtner GC, Werner S, Barrandon Y, Longaker MT, (2008) Wound repair and regeneration. Nature 453: 314-321.
14. Longaker MT, Whitby DJ, Ferguson MW, Lorenz HP, Harrison MR, et al. (1994) Adult skin wounds in the fetal environment heal with scar formation. Ann Surg 219: 65-72.
15. Lorenz HP, Longaker MT, Perkocha LA, Jennings RW, Harrison MR, et al. (1992) Scarless wound repair: a human fetal skin model. Development 114: 253-259.
16. Hohlfeld J, de Buys Roessingh A, Hirt-Burri N, Chaubert P, Gerber S, et al. (2005) Tissue engineered fetal skin constructs for paediatric burns. Lancet 366: 840-842.
17. Ramelet AA, Hirt-Burri N, Raffoul W, Scaletta C, Pioletti DP, et al. (2009) Chronic wound healing by fetal cell therapy may be explained by differential gene profiling observed in fetal versus old skin cells. Exp Gerontol 44: 208-218.
18. Rowlatt U, (1979) Intrauterine wound healing in a 20 week human fetus. Virchows Arch A Pathol Anat Histol 381: 353-361.
19. Johnen C, Chinnici C, Triolo F, Plettig J, Brautigam K,et al. (2012) Phenotypical characterization of 6-21-week gestational age human dermis and epidermal cell isolation methods for in vitro studies on epidermal progenitors. Burns.
20. Eckes B, Zweers MC, Zhang ZG, Hallinger R, Mauch C, et al. (2006) Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. J Investig Dermatol Symp Proc 11: 66-72.
21. Margadant C, Charafeddine RA, Sonnenberg A, (2010) Unique and redundant functions of integrins in the epidermis. Faseb J 24: 4133-4152.
22. Jones PH, Watt FM, (1993) Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73: 713-724.
23. Adams JC, Watt FM, (1990) Changes in keratinocyte adhesion during terminal differentiation: reduction in fibronectin binding precedes alpha 5 beta 1 integrin loss from the cell surface. Cell 63: 425-435.
24. Foglia RP, DiPreta J, Statter MB, Donahoe PK, (1986) Fetal allograft survival in immunocompetent recipients is age dependent and organ specific. Ann Surg 204: 402-410.
25. Shen H, Yao P, Lee E, Greenhalgh D, Soulika AM, (2012) Interferon-gamma inhibits healing post scald burn injury. Wound Repair Regen 20: 580-591.
26. Beidler SK, Douillet CD, Berndt DF, Keagy BA, Rich PB, et al. (2009) Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J Vasc Surg 49: 1013-1020.
27. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, et al. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191-1193.
28. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, et al. (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196: 447-457.
29. Hainz U, Jurgens B, Heitger A, (2007) The role of indoleamine 2,3-dioxygenase in transplantation. Transpl Int 20: 118-127.
30. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, et al. (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196: 459-468.
31. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, et al. (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189: 1363-1372.
32. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, et al. (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621.
33. Chavez-Munoz C, Hartwell R, Jalili RB, Carr M, Kilani RT, et al. (2012) Application of an indoleamine 2,3-dioxygenase-expressing skin substitute improves scar formation in a fibrotic animal model. J Invest Dermatol 132: 1501-1505.
34. Forouzandeh F, Jalili RB, Hartwell RV, Allan SE, Boyce S, et al. (2010) Local expression of indoleamine 2,3-dioxygenase suppresses T-cell-mediated rejection of an engineered bilayer skin substitute. Wound Repair Regen 18: 614-623.
35. Martin P, D'Souza D, Martin J, Grose R, Cooper L, et al. (2003) Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr Biol 13: 1122-1128.
36. Szpaderska AM, Egozi EI, Gamelli RL, DiPietro LA, (2003) The effect of thrombocytopenia on dermal wound healing. J Invest Dermatol 120: 1130-1137.
37. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M, (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16: 585-601.
38. Werner S, Krieg T, Smola H, (2007) Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 127: 998-1008.
39. Postlethwaite AE, Raghow R, Stricklin GP, Poppleton H, Seyer JM, et al. (1988) Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta. J Cell Biol 106: 311-318.
40. Spiekstra SW, Breetveld M, Rustemeyer T, Scheper RJ, Gibbs S, (2007) Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Repair Regen 15: 708-717.
41. Waelti ER, Inaebnit SP, Rast HP, Hunziker T, Limat A, et al. (1992) Co-culture of human keratinocytes on post-mitotic human dermal fibroblast feeder cells: production of large amounts of interleukin 6. J Invest Dermatol 98: 805-808.
42. Maas-Szabowski N, Fusenig NE, (1996) Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts. J Invest Dermatol 107: 849-855.
43. Smola H, Thiekotter G, Fusenig NE, (1993) Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol 122: 417-429.
44. Szabowski A, Maas-Szabowski N, Andrecht S, Kolbus A, Schorpp-Kistner M, et al. (2000) c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103: 745-755.
45. Wang Z, Wang Y, Farhangfar F, Zimmer M, Zhang Y, (2012) Enhanced keratinocyte proliferation and migration in co-culture with fibroblasts. PLoS One 7: e40951.
46. Tuschil A, Lam C, Haslberger A, Lindley I, (1992) Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation. J Invest Dermatol 99: 294-298.
47. Michel G, Kemeny L, Peter RU, Beetz A, Ried C, et al. (1992) Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells. FEBS Lett 305: 241-243.
48. Breuhahn K, Mann A, Muller G, Wilhelmi A, Schirmacher P, et al. (2000) Epidermal overexpression of granulocyte-macrophage colony-stimulating factor induces both keratinocyte proliferation and apoptosis. Cell Growth Differ 11: 111-121.
49. Delehedde M, Lyon M, Vidyasagar R, McDonnell TJ, Fernig DG, (2002) Hepatocyte growth factor/scatter factor binds to small heparin-derived oligosaccharides and stimulates the proliferation of human HaCaT keratinocytes. J Biol Chem 277: 12456-12462.
50. Seppa H, Grotendorst G, Seppa S, Schiffmann E, Martin GR, (1982) Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol 92: 584-588.
51. Werner S, Grose R, (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83: 835-870.